- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Veterans Affairs, Veterans Health Administration (Bronx, NY)
- …and facility, participation in department and hospital wide committees, clinical duties commensurate with training, and occasional medical student educational ... care facility situated on an attractive campus in the North Bronx. Hospital affiliations include the Mount Sinai School...Systems in the US and is a leader in clinical performance, medical informatics, and electronic health records. VA… more
- Fresenius Medical Center (New York, NY)
- …qualities you'll find in the Fresenius Leadership Team. Our strength in the North American market and extensive global network provide our employees with ... career._ **Connect with your goals and change lives** **with Fresenius Medical Care North America.** Here is your opportunity to make profound connections that make… more
- Fresenius Medical Center (Brooklyn, NY)
- …qualities you'll find in the Fresenius Leadership Team. Our strength in the North American market and extensive global network provide our employees with ... career._ **Connect with your goals and change lives** **with Fresenius Medical Care North America.** Here is your opportunity to make profound connections that make… more
- Mitsubishi Chemical Group (Queens County, NY)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (New York, NY)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare ... and RADICAVA(R) (edaravone) oral suspension in 2022. The company handles research, clinical development , sales, marketing, medical affairs, and business … more